Streetbeat News

Products Services

BTCUSD

COIN

Hedge fund manager Mark Yusko predicts Bitcoin (BTC) will surpass $150,000 in 2024, doubling its current value. He suggests allocating 1% to 3% of portfolios to Bitcoin, citing it as a superior alternative to gold. Yusko highlights the upcoming Bitcoin halving and the introduction of Bitcoin ETFs as bullish catalysts, expecting a supply shock and significant price increases post-halving. Yusko's firm also holds exposure to Coinbase.

Portfolio Pulse from Bibhu Pattnaik

March 31, 2024 | 6:32 pm

TSLA

Tesla, Inc. (NASDAQ:TSLA) celebrated producing its 6 millionth vehicle, a significant milestone that CEO Elon Musk and the team acknowledged. This achievement has led analysts to revisit their Q1 delivery estimates. While Troy Teslike suggests increasing production and delivery estimates slightly, he still expects Q1 deliveries to be below last year's 422,875 units. Gary Black predicts Tesla may have delivered around 415,000 units in Q1, considering production numbers and typical gaps between production and deliveries. Tesla's stock closed down 2.25% at $175.79.

Portfolio Pulse from Shanthi Rexaline

March 31, 2024 | 3:25 pm

AAPL

AMZN

GOOGL

Apple Inc. (NASDAQ:AAPL) had a notable week with events including a rare iPhone auction fetching $130K, CEO Tim Cook's strategic visit to China, rumors of new iPhone 16 Pro colors, and a lawsuit against a former employee for leaks. Additionally, Jim Cramer criticized antitrust lawsuits against Big Tech, including Apple, Alphabet Inc. (NASDAQ:GOOGL), and Amazon.com Inc. (NASDAQ:AMZN).

Portfolio Pulse from Benzinga Neuro

March 31, 2024 | 1:19 pm

AMZN

META

MSFT

TSLA

This week in AI featured major developments from industry leaders like Elon Musk's xAI, Tesla, Meta Platforms, and Microsoft. Musk announced Grok 2, aiming to outperform competitors. Tesla is hiring for its Optimus Humanoid Robot, indicating a potential launch. Zuckerberg is personally recruiting AI talent from Google's DeepMind for Meta. Speculation about an AI bubble involves Nvidia, Amazon, and Microsoft, with warnings from analyst Richard Windsor. Microsoft's stock is predicted to rise due to its AI advancements.

Portfolio Pulse from Benzinga Neuro

March 31, 2024 | 5:16 am

COIN

DOGEUSD

ETHUSD

SHIBUSD

The cryptocurrency market had an eventful week with Dogecoin's pre-Doge Day rally, Ethereum's co-founder Vitalik Buterin commenting on the Metaverse, Edward Snowden's prediction on the SEC's case against Coinbase, a trader's significant profit from Dawkoin, and Shiba Inu's strong comeback. Dogecoin saw a 40% increase in weekly gains, Ethereum's co-founder criticized the current understanding of the Metaverse, Snowden supported Coinbase against the SEC, a trader turned $3K into $215K with Dawkoin, and Shiba Inu's burn rate soared by 17,197%.

Portfolio Pulse from Benzinga Neuro

March 31, 2024 | 4:59 am

AYRWF

CURLF

GTBIF

JUSHF

PLNHF

TCNNF

AYR Wellness Inc. (OTC:AYRWF) launched its Kynd brand's premium edibles in Florida and Nevada, targeting the $2.2 billion edibles market with vegan gluten-free options. The company reported a 10% revenue increase in 2023 to $463.6 million, despite a widened net loss. The Florida cannabis market, where AYR Wellness is expanding, is valued at over $1.4 billion with a 30% growth rate. Nevada's market, also targeted by AYR, is valued at $850 million, benefiting from tourist traffic and strong economics. Other companies mentioned include Trulieve (OTC:TCNNF), Green Thumb Industries (OTC:GTBIF), Curaleaf Holdings (OTC:CURLF), Jushi Holdings (OTC:JUSHF), and Planet 13 Holdings (OTC:PLNHF).

Portfolio Pulse from Nicolás Jose Rodriguez

March 30, 2024 | 2:54 pm

CMND

CMPS

CYBN

FLHLF

HUGE

MDXXF

SILO

TRUFF

The article provides a comprehensive roundup of recent developments in the psychedelics sector, highlighting research findings, regulatory updates, and industry movements. Key highlights include the launch of Usona Institute's Phase 3 clinical trial on psilocybin for Major Depressive Disorder, partnerships for psilocybin research, and significant corporate changes within companies like Compass Pathways and Cybin. Additionally, several companies announced progress in clinical trials, patent approvals, and expansions in product distribution.

Portfolio Pulse from Lara Goldstein

March 30, 2024 | 12:57 pm

AAPL

DJT

GME

TSLA

Benzinga's weekly review highlights significant first-quarter gains for major indexes and examines bullish and bearish perspectives on stocks like Apple, Tesla, and GameStop. The S&P 500 saw a 10.2% increase, the Dow Jones 5.6%, and the Nasdaq 9.1%. Inflation and spending reports suggest delayed Fed rate cuts. Bullish views include Apple's undervaluation, Tesla's Optimus robot project, and Dogecoin's surge. Bearish takes cover GameStop's performance, Boeing's CEO resignation, and Trump Media's valuation compared to Nvidia.

Portfolio Pulse from Michael Cohen

March 30, 2024 | 12:32 pm

FSR

GOEV

KARS

NKLA

TSLA

The electric vehicle (EV) sector experienced mixed sentiments despite the broader market's record high. Tesla faced reduced delivery targets and price target cuts due to demand issues, while promoting a free trial of its full-self driving software. Fisker announced significant price reductions for its EVs amid bankruptcy rumors. Nikola teased the return of its battery EV trucks and announced the opening of a hydrogen refueling station. Canoo acquired assets from bankrupt Arrival Automotive. BYD aims for a 20% sales growth in 2024. The KraneShares Electric Vehicles ETF saw a weekly decline.

Portfolio Pulse from Shanthi Rexaline

March 30, 2024 | 12:21 pm

NVO

Sen. Bernie Sanders criticized the high prices of the diabetes drug Ozempic, produced by Novo Nordisk (NYSE:NVO), and is considering hearings and a meeting with the company's CEO to discuss price reductions. Sanders highlighted the disparity between the drug's production cost, less than $5 a month, and its selling price, nearly $1,000 a month in the U.S. Novo Nordisk defended its pricing, citing significant investments in research and development.

Portfolio Pulse from Rounak Jain

March 30, 2024 | 8:19 am